Wird geladen...
Risk factors and mechanisms contributing to TKI-induced vascular events in patients with CML(☆)
Vascular adverse events (VAE) are an emerging problem in patients with chronic myeloid leukemia (CML) receiving second-generation BCR-ABL1 tyrosine kinase inhibitors (TKI). Relevant VAE comprise peripheral, cerebral, and coronary artery changes in patients receiving nilotinib, venous and arterial oc...
Gespeichert in:
| Veröffentlicht in: | Leuk Res |
|---|---|
| Hauptverfasser: | , , , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
2017
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7115818/ https://ncbi.nlm.nih.gov/pubmed/28549238 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.leukres.2017.05.008 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|